Ferozsons Laboratories Limited

KASE:FEROZ Stock Report

Market Cap: PK₨11.1b

Ferozsons Laboratories Past Earnings Performance

Past criteria checks 4/6

Ferozsons Laboratories has been growing earnings at an average annual rate of 7.2%, while the Pharmaceuticals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 20% per year. Ferozsons Laboratories's return on equity is 6.3%, and it has net margins of 3.3%.

Key information

7.2%

Earnings growth rate

7.2%

EPS growth rate

Pharmaceuticals Industry Growth20.2%
Revenue growth rate20.0%
Return on equity6.3%
Net Margin3.3%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Ferozsons Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KASE:FEROZ Revenue, expenses and earnings (PKR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2415,1364944,3210
31 Dec 2314,5163953,8540
30 Sep 2313,3194083,5910
30 Jun 2311,4572713,2050
31 Mar 2310,7431643,1850
31 Dec 2210,1734093,0450
30 Sep 229,6745872,8350
30 Jun 229,3307342,6510
31 Mar 229,7881,2632,5560
31 Dec 219,5821,2652,4140
30 Sep 219,5931,3302,2360
30 Jun 218,8791,1732,0850
31 Mar 217,6199171,7300
31 Dec 207,0497371,6800
30 Sep 206,3854561,7240
30 Jun 206,2124171,7050
31 Mar 206,3743351,8660
31 Dec 196,0002481,8650
30 Sep 195,9262071,7790
30 Jun 195,8032011,7180
31 Mar 195,249771,6140
31 Dec 185,162831,5930
30 Sep 185,180161,5490
30 Jun 185,00371,4800
31 Mar 185,111-321,4890
31 Dec 174,8362131,3830
30 Sep 174,7072441,3270
30 Jun 175,0023961,3400
31 Mar 175,6676691,4500
31 Dec 167,4949171,5070
30 Sep 169,6021,6751,5720
30 Jun 1611,2952,2041,5470
31 Mar 1611,3902,3431,4110
31 Dec 1510,1132,1211,3080
30 Sep 157,8601,5281,2180
30 Jun 155,7119051,1770
31 Mar 154,6896971,1410
31 Dec 144,0515731,1150
30 Sep 143,8255421,0720
30 Jun 143,8325261,0380
31 Mar 143,6405799400
31 Dec 133,3795059120
30 Sep 133,1714698830

Quality Earnings: FEROZ has a high level of non-cash earnings.

Growing Profit Margin: FEROZ's current net profit margins (3.3%) are higher than last year (1.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: FEROZ's earnings have grown by 7.2% per year over the past 5 years.

Accelerating Growth: FEROZ's earnings growth over the past year (201.6%) exceeds its 5-year average (7.2% per year).

Earnings vs Industry: FEROZ earnings growth over the past year (201.6%) exceeded the Pharmaceuticals industry 22%.


Return on Equity

High ROE: FEROZ's Return on Equity (6.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.